Hypertension

Abstract

This is the final “ Hypertension Update” for our current team of editors. We greatly appreciate the tremendous support from the many authors who have submitted their best research for consideration, the reviewers and editorial board members who have committed valuable time and energy to ensure that the best manuscripts are selected for publication, and the many loyal readers who have provided feedback that has improved the journal over the past 10 years of our editorship. It has been a privilege and a great pleasure to serve the readers of Hypertension and the American Heart Association (AHA). Our main objectives for Hypertension from the beginning have been (1) to publish the highest quality original basic and clinical research relating to hypertension; (2) to increase the readership and scientific importance of Hypertension ; (3) to ensure rapid and fair manuscript reviews, rapid publication of articles, and to provide the highest possible level of efficiency and “customer satisfaction” in our office operations; and (4) to effectively serve the international community of hypertension researchers and clinicians, and provide an important vehicle for achieving the mission of the AHA. As noted in a previous review of the history of Hypertension ,1 we were fortunate that our predecessors handed the journal to us in good shape. Although Hypertension had a difficult birth, it rapidly became the leading journal in its field under the successive editorships of Harriet Dustan (founding editor, University of Alabama-Birmingham), Ed Haber (Harvard University), Allyn Mark and Jerry DiBona (University of Iowa), and Ed Frohlich (Tulane University).1 When the editorship was transferred to us in 2002, we assembled an international team of editors for the first time in the journal's history. The Associate Editors included Joey Granger, Dan Jones and Celso Gomez-Sanchez from the University of Mississippi Medical Center, Curt …